These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 31965838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lacticaseibacillus rhamnosus GG and Saccharomyces cerevisiae boulardii supplementation exert protective effects on human gut microbiome following antibiotic administration in vitro.
    Duysburgh C, Van den Abbeele P, Morera M, Marzorati M.
    Benef Microbes; 2021 Aug 30; 12(4):59-73. PubMed ID: 34190033
    [Abstract] [Full Text] [Related]

  • 3. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
    Chan MZA, Toh M, Liu SQ.
    Int J Food Microbiol; 2021 Jul 16; 350():109229. PubMed ID: 34023682
    [Abstract] [Full Text] [Related]

  • 4. Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut models.
    Roussel C, De Paepe K, Galia W, de Bodt J, Chalancon S, Denis S, Leriche F, Vandekerkove P, Ballet N, Blanquet-Diot S, Van de Wiele T.
    Gut Microbes; 2021 Jul 16; 13(1):1953246. PubMed ID: 34432600
    [Abstract] [Full Text] [Related]

  • 5. Effect of Lactobacillus rhamnosus NCDC 298 with FOS in Combination on Viability and Toxin Production of Enterotoxigenic Escherichia coli.
    Anand S, Mandal S, Tomar SK.
    Probiotics Antimicrob Proteins; 2019 Mar 16; 11(1):23-29. PubMed ID: 28948579
    [Abstract] [Full Text] [Related]

  • 6. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
    Waitzberg D, Guarner F, Hojsak I, Ianiro G, Polk DB, Sokol H.
    Adv Ther; 2024 Mar 16; 41(3):901-914. PubMed ID: 38286962
    [Abstract] [Full Text] [Related]

  • 7. A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model.
    Zhang W, Zhu YH, Yang JC, Yang GY, Zhou D, Wang JF.
    PLoS One; 2015 Mar 16; 10(4):e0125717. PubMed ID: 25915861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. AI-2/LuxS Quorum Sensing System Promotes Biofilm Formation of Lactobacillus rhamnosus GG and Enhances the Resistance to Enterotoxigenic Escherichia coli in Germ-Free Zebrafish.
    Deng Z, Hou K, Valencak TG, Luo XM, Liu J, Wang H.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0061022. PubMed ID: 35700135
    [Abstract] [Full Text] [Related]

  • 11. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88.
    Roselli M, Finamore A, Britti MS, Mengheri E.
    Br J Nutr; 2006 Jun 31; 95(6):1177-84. PubMed ID: 16768842
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances.
    Li XQ, Zhu YH, Zhang HF, Yue Y, Cai ZX, Lu QP, Zhang L, Weng XG, Zhang FJ, Zhou D, Yang JC, Wang JF.
    PLoS One; 2012 Jun 31; 7(7):e40666. PubMed ID: 22848393
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Saccharomyces cerevisiae decreases inflammatory responses induced by F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells.
    Zanello G, Meurens F, Berri M, Chevaleyre C, Melo S, Auclair E, Salmon H.
    Vet Immunol Immunopathol; 2011 May 15; 141(1-2):133-8. PubMed ID: 21354630
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
    Thévenot J, Cordonnier C, Rougeron A, Le Goff O, Nguyen HT, Denis S, Alric M, Livrelli V, Blanquet-Diot S.
    Appl Microbiol Biotechnol; 2015 Nov 15; 99(21):9097-110. PubMed ID: 26084888
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.